p53 mutation in plasma DNA and its prognostic value in breast cancer patients

scientific article published on 01 August 2001

p53 mutation in plasma DNA and its prognostic value in breast cancer patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11489795

P2093author name stringWu J
Nguyen M
Shao ZM
Shen ZZ
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectbreast cancerQ128581
P304page(s)2222-2227
P577publication date2001-08-01
P1433published inClinical Cancer ResearchQ332253
P1476titlep53 mutation in plasma DNA and its prognostic value in breast cancer patients
P478volume7

Reverse relations

cites work (P2860)
Q36778016An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma
Q36393312Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients
Q37690204Circulating nucleic acids as biomarkers in breast cancer
Q37164447Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls
Q46790581Free circulating tumor DNA as a diagnostic marker for breast cancer.
Q81228599Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis
Q26741204Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
Q33320177Modeling cancer progression via pathway dependencies
Q40483796Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies
Q33790229Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker
Q35670356Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients
Q35810123Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature
Q59233182Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer
Q24802349The p53 pathway in breast cancer
Q34668320The prognostic molecular markers in hepatocellular carcinoma
Q52622918The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis.
Q55252785Tumour Markers: Rationale Use.
Q35790070Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma

Search more.